Fibroblast Growth Factors Market Global Forecast Report 2025-2030: Opportunities in Regenerative Medicine, Oncology, and Metabolic Disorders Due to Advances in Molecular Biology, Delivery ...
Cybin Inc. Common Shares (CYBN)
Company Research
Source: Yahoo! Finance
Key opportunities involve enhanced delivery methods, regulatory support, and strategic collaborations, driving innovation and addressing unmet clinical needs. Dublin, Nov. 14, 2025 (GLOBE NEWSWIRE) -- The "Fibroblast Growth Factors Market - Global Forecast 2025-2030" report has been added to ResearchAndMarkets.com's offering. Fibroblast growth factors (FGFs) are integral to the evolving landscape of advanced therapies and diagnostics, presenting decision-makers with opportunities to address unmet clinical and research challenges. This report offers actionable intelligence on FGF trends, regulatory shifts, and emerging opportunities, enabling senior leaders to position their organizations at the forefront of this dynamic market. The fibroblast growth factor market is undergoing rapid transformation, driven by advances in molecular biology, protein engineering, and delivery technology. Market participants include a blend of established industry leaders, emerging biotech firms, and
Show less
Read more
Impact Snapshot
Event Time:
CYBN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CYBN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CYBN alerts
High impacting Cybin Inc. Common Shares news events
Weekly update
A roundup of the hottest topics
CYBN
News
- Cybin (OTCMKTS:CYBN) had its "buy" rating reaffirmed by analysts at Guggenheim.MarketBeat
- Cybin Inc (CYBN) Q2 2026 Earnings Call Highlights: Strategic Advancements Amid Financial Challenges [Yahoo! Finance]Yahoo! Finance
- Cybin (OTCMKTS:CYBN) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $70.00 to $45.00. They now have a "buy" rating on the stock.MarketBeat
- Cybin (OTCMKTS:CYBN) had its price target lowered by analysts at HC Wainwright from $150.00 to $55.00. They now have a "buy" rating on the stock.MarketBeat
- Cybin Inc. (CYBN) Q2 2026 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
CYBN
Earnings
- 11/14/25 - Miss
CYBN
Sec Filings
- 11/26/25 - Form 6-K
- 11/26/25 - Form D
- 11/14/25 - Form SCHEDULE
- CYBN's page on the SEC website